Fostamatinib combined with TPO‐RAs or steroids as a bridge to monotherapy or as time‐limited continuous treatment in relapsed chronic ITP: A single‐centre case series

Data may be made available from the corresponding author upon reasonable request. Table S1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.